JOURNAL OF IIMER May 2026 Rowan Gardner, co-founder of PrecisionLife, a UK-based precision medicine company, brings over thirty years of experience applying computational methods to life science and patient data. Her work at PrecisionLife focuses on identifying novel disease mechanisms and therapeutic targets through advanced combinatorial analytics applied to complex disease datasets, including ME. In this session she examines new mechanistic insights into ME from large-scale genomic analysis, and considers what emerging findings may offer for future research directions. Ana Palacio - University of Miami, presents follow-up findings from the Covid-UPP trial, examining outcomes in post-COVID patients and contributing to the growing evidence base on cardiovascular and systemic effects of long COVID and related post-viral conditions. Leo Tamariz - University of Miami, presents a comparison of cardiovascular symptoms across ME, long COVID, and Gulf War Syndrome (GWS) cohorts. This cross-condition analysis contributes to understanding the shared and distinct physiological features of post-viral and post-toxic multi-symptom illnesses, with implications for diagnosis and clinical management. Mari Gamme Sollie and Trine Alm Holterbakken - Røysumtunet, Norway, present on specialised care for seriously and very seriously ill people with ME. Røysumtunet is a Norwegian facility with particular expertise in managing severely affected ME patients, and this presentation addresses one of the most underserved areas in ME clinical practice - the provision of appropriate, safe, and informed care for those who are housebound or bedbound. Friðbjörn Sigurðsson - Akureyri Hospital, Iceland, and EMERG member, presents on clinical approaches to treatment in ME. Drawing on clinical experience from Iceland's national hospital in Akureyri, this presentation addresses the practical management of ME patients and contributes to EMERG's work on developing harmonised European clinical protocols. Per Julin - Karolinska Universitetssjukhuset, Sweden, and EMERG member, presents on the Karolinska Policlinic for Post-infectious Diseases, covering both its clinical work and associated research programme. The Karolinska clinic represents one of Europe's dedicated post-infectious disease centres, and this presentation describes its approach to the assessment and management of ME and related conditions alongside the research it generates. Invest in ME Research Page 32 of 35
34 Publizr Home